India: Girls died by suicide, not slain by rapists

NEW DELHI (AP) — India's top federal investigating agency says that two teenage girls believed to have been raped and hanged by their attackers actually committed suicide.
Toyota recalls more cars for dangerous Takata air bags

A security guard walks under the logo of Toyota Motor Corp in TokyoBy Chang-Ran Kim and Mari Saito TOKYO (Reuters) - Toyota Motor Corp said on Thursday it would recall 57,000 vehicles globally to replace potentially deadly air bags made by Takata Corp, as a safety crisis around the Japanese auto parts maker looks far from being contained. Toyota's action follows a recall by rival Honda Motor Co for the same problem two weeks ago after revelations of a fifth death, in Malaysia, linked to Takata's air bag inflator. ...



Afghan attack targets British embassy car, 5 dead

KABUL, Afghanistan (AP) — A suicide bomber attacked a British embassy vehicle in the Afghan capital Kabul on Thursday, killing at least five Afghan civilians and wounding more than 30 others, officials said.
Protesters dwindle to small groups in Ferguson

Snow falls as Missouri National Guard stand outside of the Ferguson Police Department Wednesday, Nov. 26, 2014, in Ferguson, Mo. A grand jury's decision not to indict Ferguson police officer , Darren Wilson, in the shooting death of Michael Brown has sparked protests nationwide, triggering debates over the relations between black communities and law enforcement. (AP Photo/Jeff Roberson)FERGUSON, Mo. (AP) — The throngs of protesters who overran Ferguson after the grand jury decision in the Michael Brown case dwindled to just a few small groups as people began cleaning up this battered community and seeking something closer to a normal routine.



Ebola vaccine from Glaxo passes early safety test

A nurse holds a syringe containing an experimental Ebola vaccine during a media visit at the CHUV in LausanneNEW YORK (Reuters) - An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine. The trial, which began on Sept. 2 and will monitor the volunteers for 48 weeks, is primarily aimed at assessing how safe the vaccine is. But the immune response offered hope that it would also be effective. ...





Close Window